Breaking barriers in psoriasis

Today's post is written by Thom Thorp, Head Government Affairs and Communications, Europe and Canada & Senior Director Corporate Affairs and Market Access, Lilly UK and Northern European Hub.

This World Psoriasis Day, we joined the International Federation of Psoriasis Associations in asking if the needs of the 4 million people in Europe living with psoriasis are being met.

Psoriasis is a debilitating condition, which can have psychosocial impacts, and shares risk factors with other chronic diseases like heart disease and diabetes.

The launch of the first World Health Organization (WHO) Resolution on psoriasis in 2014, and this year’s follow-up Global Report on Psoriasis, have put the public health impact of this condition into focus. These are critical milestones, validating the needs of a hugely impacted group of patients.

So, what actions have European Member States taken to address incorrect or delayed diagnosis, inadequate treatment options and insufficient access to care— all highlighted by WHO as causes of needless suffering for people with psoriasis?

We’ve commissioned the Economist Intelligence Unit (EIU) to investigate what measures countries have put in place to achieve the aims of the WHO Resolution, exploring questions like: Are patients having enough share of voice in the provision of psoriasis care? Do people have equal access to psoriasis clinics across, or even within, Member States? Is integrated care in place and effectively delivered?

This piece of research will present the different experiences of people with psoriasis in Spain as compared to people with psoriasis in Germany and across other Member States, to help inform conversations with policy makers, healthcare professionals and others working to improve the quality of life of people with psoriasis.

The results from the report will be made available in early 2017, providing a benchmark for ministers of health and regional health policymakers in the European Union to assess progress made to date against the directives of the WHO Resolution; as well as identify where more needs to be done.

Working together, we hope to identify smart, resourceful ways of improving the care and support of people with psoriasis, and breaking down barriers to improve their health, productivity and overall happiness.

Stay tuned for results in 2017.